載入...
Dual roles for immune metagenes in breast cancer prognosis and therapy prediction
BACKGROUND: Neoadjuvant chemotherapy for breast cancer leads to considerable variability in clinical responses, with only 10 to 20% of cases achieving complete pathologic responses (pCR). Biological and clinical factors that determine the extent of pCR are incompletely understood. Mounting evidence...
Na minha lista:
| 發表在: | Genome Med |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4240891/ https://ncbi.nlm.nih.gov/pubmed/25419236 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13073-014-0080-8 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|